Spironolactone
Spironol contains the active substance spironolactone. Spironol belongs to a group of medicines called diuretics, also known as water tablets.
The reason for the patient's visit to the doctor may be swelling of the ankles or shortness of breath. These symptoms may occur if the heart's pumping function weakens due to too much fluid in the body. This is called congestive heart failure.
The need to pump excess fluid throughout the body means that the heart has to work harder. The doctor prescribes Spironol to the patient to get rid of excess fluid from the body. As a result, the heart will be able to work less hard.
Excess fluids are removed in the urine, so during Spironol treatment, it may be necessary to use the toilet more often.
Spironol may also be used in the following conditions:
If the patient has the above conditions, Spironol will help get rid of excess fluid from the body.
If, after taking Spironol, the patient does not feel better or feels worse, they should consult a doctor.
Children should only be treated under the supervision of a pediatrician.
Spironolactone is contraindicated in children and adolescents with moderate or severe renal impairment.
Before starting Spironol, the patient should discuss it with their doctor or pharmacist.
Taking Spironol with certain medicines, potassium supplements, or potassium-rich foods may lead to severe hyperkalemia (elevated potassium levels in the blood). Symptoms of severe hyperkalemia may include muscle cramps, heart rhythm disturbances, diarrhea, nausea, dizziness, or headache.
In the event of kidney dysfunction or failure, the patient may experience a dangerous increase in potassium levels in the blood. This can affect heart function and, in extreme cases, lead to death.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
If the patient is taking abiraterone for the treatment of prostate cancer, they should inform their doctor.
The patient should inform their doctor if they are taking mitotane for the treatment of adrenal gland cancer. This medicine should not be taken with mitotane.
The doctor may change the dose of Spironol if the patient is taking any of the following medicines:
Spironol weakens the response to norepinephrine.
If the patient is to undergo surgery with anesthesia, they should inform their doctor about taking Spironol.
This medicine should be taken with food (see section 3 "How to take Spironol").
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
There is limited data on the use of Spironol in pregnant women. The doctor will only prescribe Spironol if the potential benefits outweigh the potential risks.
Breastfeeding
Spironol should not be taken by breastfeeding mothers. The patient should discuss with their doctor, who may advise on an alternative method of feeding the baby during treatment with this medicine.
Care should be taken when driving or operating machinery.
Drowsiness and dizziness associated with taking Spironol may affect the ability to drive or operate machinery.
If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicinal product.
This medicinal product contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
This medicine should always be taken exactly as prescribed by the doctor. If in doubt, the patient should consult their doctor or pharmacist.
The amount of tablets taken depends on the severity of the disease. This medicine should be taken once a day, with food.
The dose for adults is 25 mg to 400 mg of spironolactone per day, depending on the disease being treated.
If in doubt, the patient should consult their doctor or pharmacist.
The doctor will start treatment with a low initial dose and then gradually increase the dose as needed until the desired effect is achieved.
If Spironol is taken by children, the number of tablets depends on the child's body weight.
The doctor will determine the dose individually.
In case of accidental ingestion of too many tablets, the patient should immediately contact their doctor or go to the emergency department of the nearest hospital. Symptoms of overdose include: drowsiness, dizziness, nausea, vomiting, diarrhea, feeling of dehydration, confusion. A rash may appear in the form of flat reddened surfaces on the skin with small bumps. Very large overdose can lead to changes in sodium and potassium levels in the blood with weakness, tingling, numbness, or muscle cramps.
If the patient forgets to take a Spironol tablet, they should take it as soon as possible, unless it is almost time for the next dose. The patient should not take a double dose to make up for the missed dose.
Spironol should be taken for as long as prescribed by the doctor. The patient should not stop taking the medicine without consulting their doctor, even if they feel better. If the patient stops taking the medicine too quickly, their condition may worsen.
If the patient has any further questions about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Spironol can cause side effects, although not everybody gets them.
The patient should immediately inform their doctorif they experience any of the following symptoms after taking the medicine. Although these symptoms are very rare, they can be serious.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Frequency not known: cannot be estimated from the available data
If the patient experiences any side effects, including those not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "EXP".
The expiry date refers to the last day of the month stated.
Store in a temperature below 25°C.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Round, flat tablets, almost white to cream-colored, with a score line allowing for division, with an inscription on one side of the tablet. The score line on the tablet is only to facilitate breaking the tablet to make it easier to swallow and not to divide it into equal doses.
Spironol is packaged in blisters of aluminum/PVC foil placed in a cardboard box. The box contains 20 or 100 tablets and a patient leaflet.
GEDEON RICHTER POLSKA Sp. z o.o., ul. Ks. J. Poniatowskiego 5, 05-825 Grodzisk Mazowiecki, Poland, tel.: (22) 755 50 81. For more information about the medicine, the patient should contact: GEDEON RICHTER POLSKA Sp. z o.o., ul. Ks. J. Poniatowskiego 5, 05-825 Grodzisk Mazowiecki, tel. +48 (22)755 96 48, lekalert@grodzisk.rgnet.org.
((marketing authorization holder's logo))
((pharmacode))
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.